Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases. (Q39329517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

review article

1 reference

title

Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

main subject

cardiovascular disease

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Nasser Hashemi Goradel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Farshid Ghiyami- Hour

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Babak Negahdari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Ziba Vaisi Malekshahi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Milad Hashemzehi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Aria Masoudifar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

12 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Biochemistry

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

95-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Mesenchymal stem cells: clinical applications and biological characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Epidemiology and risk profile of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

21 January 2018

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cell therapy in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Current and Future Status of Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Non-viral methods for generating integration-free, induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Challenges in identifying the best source of stem cells for cardiac regeneration therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Therapeutic use of stem cells for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

The incidence of congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

New strategies for improving stem cell therapy in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Long-Term Trends in the Incidence of and Survival with Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Stem cell engineering for treatment of heart diseases: potentials and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

The potential of cardiac stem cell therapy for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

The kynurenine system and immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Stem cells and repair of the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Signaling molecules, transcription growth factors and other regulators revealed from in-vivo and in-vitro models for the regulation of cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Organogenesis of the vertebrate heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

SiRNA and epigenetic aberrations in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Mesenchymal stem cell: a new horizon in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Stem cell therapy for heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiomyocyte differentiation of mouse and human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Epidemiology and cost of advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Induced pluripotency and oncogenic transformation are related processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Primordial germ cell-derived mouse embryonic germ (EG) cells in vitro resemble undifferentiated stem cells with respect to differentiation capacity and cell cycle distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiac stem cell therapy: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Potential myogenic stem cell populations: sources, plasticity, and application for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Stem-cell therapy for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiac and skeletal muscle development in P19 embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Purification and characterization of mouse hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cell therapy for heart disease: great expectations, as yet unmet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Toward clinical application of stem cells for cardiac regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Bone marrow cell transplantation in Chagas' disease heart failure: report of the first human experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Clinical applications of stem cells for the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Myoblast transplantation for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Effects of Adipose Tissue-Derived Stem Cell Therapy After Myocardial Infarction: Impact of the Route of Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

Allogeneic adipose stem cell therapy in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26169

21 January 2018

Identifiers

DOI

10.1002/JCB.26169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28543595%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference